Cencora, Inc. vs Abbvie Inc.
COR vs ABBV — side-by-side comparison from reported financials. COR leads 8, ABBV leads 4 of 12 comparable metrics.
Cencora, Inc.
COR · Healthcare
$323.85+0.78%Solid
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | COR | ABBV |
|---|---|---|
| Price | $323.85 | $276.43 |
| Market cap | $61.8B | $488B |
| Revenue (TTM) | $333B | $64.4B |
| Revenue growth | +10.4% | +1.8% |
| Net margin | 0.8% | 9.8% |
| Free cash flow | $4.06B | $18.2B |
| Net cash (debt) | ($3.30B) | ($56.2B) |
| 1-year price return | +3.1% | +19.8% |
| P/E | 23.5 | 77.4 |
| P/E vs own history (cheap-side %) | 83% | 23% |
| Dividend yield | 0.76% | 2.45% |
| Return on equity | 106% | 96% |
| Altman Z-score | 3.66 | 2.33 |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 51,000 | 57,000 |
Full résumé-style profiles: COR CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.